Ellis Andrea — SEC Form 4 filings
SEC reporting owner CIK 1877680. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-13.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-25 to 2026-07-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 5 legs across 5 filings — 139,255 shares, $7,866,013 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: sale of 64,921 shares @ $64.87 ($4,211,302) in BridgeBio Pharma, Inc., filed 2026-03-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | Director | 8 | — | 5 legs · 139,255 sh · $7,866,013 | 15 |
Form 4 filings — Ellis Andrea
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-13 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 17,167 @ $16.75 · Sale (S): 17,167 @ $84 · Option exercise (M): 17,167 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 3,990 @ $0 · Grant/award (A): 5,277 (derivative) @ $0 | EDGAR |
| 2026-03-06 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 64,921 @ $8.45 · Sale (S): 64,921 @ $64.87 · Option exercise (M): 64,921 (derivative) @ $0 | EDGAR |
| 2025-08-07 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 17,167 @ $16.75 · Sale (S): 17,167 @ $49 · Option exercise (M): 17,167 (derivative) @ $0 | EDGAR |
| 2025-06-24 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 6,589 @ $0 · Grant/award (A): 8,425 (derivative) @ $0 | EDGAR |
| 2025-04-16 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 10,000 @ $8.45 · Sale (S): 10,000 @ $35 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-04-03 | 4 | BridgeBio Pharma, Inc. (BBIO) | Option exercise (M): 30,000 @ $8.45 · Sale (S): 30,000 @ $34.05 · Option exercise (M): 30,000 (derivative) @ $0 | EDGAR |
| 2024-06-25 | 4 | BridgeBio Pharma, Inc. (BBIO) | Grant/award (A): 26,014 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1877680 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →